Analytical Chip Technology - U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays, 3rd. Edition

Kalorama Information
November 1, 2007
276 Pages - SKU: KLI1393085
Countries covered: United States

Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very broad — covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis.

Kalorama's Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein and other Microarrasys) 3rd. Edition looks at the market for analytical microchips with a unique methodology -- the market is expressed in terms of its potential as opposed to experienced and projected revenues. As the author Ken Krul states,

"The status of the current market in terms of revenues is misleading of the potential market as a whole. It does not allow for the understanding of the potential of unmet need. The difference can be as stark as the difference between the surface of the sun and the dark side of the moon."
This is a particular important point in a growing research-based market such as analytical chips. In this report, Krul's unique analysis is based on:
  • The current and expected levels of genomic and proteomic research;
  • The general trends in technological development for genomics and proteomics, and other factors that affect those trends;
  • The trends in pharmaceutical research and development, both in terms of technology and the need for high-throughput approaches and equipment; and
  • Costs of analysis based on studies of actual research and projected costs of new technologies by those engaged in their development.
The report breaks up microchip usage into the following segments and forecasts to 2017:
  • DNA/Genetics
  • Protein
  • Cell
  • Tissue
  • Microbiology
  • Process ("Lab on a Chip")
The analysis presented in this report is based on data from a combination of company, government, industrial, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including experts in genomics and proteomics, pathologists, research scientists, and business development and marketing managers.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.




More Drug Discovery reports by Kalorama Information

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition by Kalorama Information
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process.This Kalorama Information ...
Laboratory Information Systems (LIS / LIMS): Software, Hardware and Service Markets for Clinical Labs and Drug Discovery Labs by Kalorama Information
Laboratory Information Systems (LIS / LIMS) Markets (Clinical Laboratory Software and Hardware, Drug Discovery Systems) Laboratory information systems (LIS), also known as laboratory ...
The World Market for Pain Management Drugs and Devices by Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain ...
Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends) by Kalorama Information
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable ...
See all reports like this >>

More United States Drug Discovery reports

PharmaPoint: Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023 by GlobalData
PharmaPoint: Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023SummaryGlobalData estimates that the total market size for the 7MM in 2013 was ...
Physician Views: Sovaldi revolutionises hepatitis C in the US, but what about uptake in the EU5? by FirstWord
Uptake and usage of Gilead Sciences' Sovaldi (sofosbuvir) in the US market has been closely tracked since FDA approval last December – but how are ...
PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023 by GlobalData
PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023SummaryMajor depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. ...
Market Highlights: US Systemic Lupus Erythematosus – 2014 by Fore Pharma
US Systemic Lupus Erythematosus Market Highlights – 2014The latest research, 'US Systemic Lupus Erythematosus Market Highlights – 2014', provides the US systemic lupus erythematosus market ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 995  
    Hard Copy Mail Delivery  USD 4,395  
    Departmental License (up to 10 users one location)  USD 5,495  
    Global Site License  USD 1,990  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!